Brentuximab vedotin | CD markers inhibitor | Read Reviews & Product Use Citations

Brentuximab vedotin (SGN-35; Adcetris,cAC10-vcMMAE) is an anti-CD30 antibody conjugated via a protease-cleavable linker to the potent anti-microtubule agent monomethyl auristatin E (MMAE). Brentuximab vedotin can be used for the research of relapsed and refractory Hodgkin lymphoma.

CAS No. 914088-09-8

Click to purchase products related to Brentuximab vedotin

Purity & Quality Control

Batch: D404501 Purity: 98.93% Protein concentration: 9.36mg/ml Endotoxin Level: ＜1EU/mg

98.93

Choose Selective CD markers Inhibitors

Biological Activity

Description	Brentuximab vedotin (SGN-35; Adcetris,cAC10-vcMMAE) is an anti-CD30 antibody conjugated via a protease-cleavable linker to the potent anti-microtubule agent monomethyl auristatin E (MMAE). Brentuximab vedotin can be used for the research of relapsed and refractory Hodgkin lymphoma.

References
[1] van de Donk NW, et al. MAbs. 2012;4(4):458-465.

References

[1] van de Donk NW, et al. MAbs. 2012;4(4):458-465.

Product Details

CAS No.	914088-09-8
DAR	4.2
ADC antiody	Brentuximab
ADC cytotoxin	MMAE
Formulation	1xPBS
Storage (From the date of receipt)	Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field